- CERo Therapeutics (CERO) +625% after it announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients.
- Lytus Technologies (LYT) +210% after it enters $326 billion data center market with launch of cutting-edge Lytus Cloud Infrastructure Services.
- Brera Holdings BREA +131% after Executive Chairman Daniel McClory acquires majority stake.
- Immuron IMRN +91% after mid-stage data for antidiarrheal med.
- ImmunoPrecise Antibodies (IPA) +43% after subsidiary BioStrand unveils major breakthrough in Life Sciences with advanced foundation AI model.
- Honest Company HNST +33% after reporting a profit in Q4, driven by a 10% increase in sales, both of which exceeded estimates.
- Rush Street Interactive RSI +28% after strong Q4 earnings report.
- Mind Medicine MNMD +26% on FDA breakthrough status for anxiety disorder therapy.
- OneSpan OSPN +26% on Q4 earnings report.
- Yext YEXT +23% on Q4 earnings report.
- Rentokil Initial (RTO) +17% after full-year 2023 preliminary results showed adjusted pre-tax profit jumping 43.8% to £766M, with revenues up 44.7% to £5.4B.
- Chemours CC +18% an internal review found its top three executives had manipulated some vendor payments and collections of receivables in part to meet free cash flow targets that were tied to their incentives.
- Avinger AVGR +16% after it enters partnership with Zylox-Tonbridge, to get $15 million of equity funding.
- Ventyx Biosciences VTYX +13% after $100M private placement.
- AudioEye AEYE +16% on Q4 earnings result.
- QuantaSing QSG +16% on Q2 earnings result.
- SciSparc (SPRC) +15% after granted patent for core technology in multiple jurisdictions in Europe.
- Treasure Global (TGL) +13%.
- Neximmune (NEXI) +13%.
- American Eagle Outfitters AEO +13% on Q4 earnings release.
- XORTX Therapeutics (XRTX) 12%.
- Avangrid AGR 11% after Iberdrola offers to buy remaining Avangrid shares for $2.49B.
- NKGen Biotech (NKGN) 16%.
- Clearmind Medicine (CMND) 10%.
- Liveperson (LPSN) 10%.